Rohto Pharmaceutical Co.,Ltd.
RPHCF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $3,326 | $682,253 | $4,583 | $705,762 |
| - Cash | $526 | $77,161 | $392 | $64,502 |
| + Debt | $339 | $50,223 | $247 | $44,536 |
| Enterprise Value | $3,139 | $655,315 | $4,438 | $685,796 |
| Revenue | $569 | $551 | $552 | – |
| % Growth | 3.1% | -0.1% | – | – |
| Gross Profit | $315 | $302 | $317 | – |
| % Margin | 55.3% | 54.7% | 57.4% | – |
| EBITDA | $135 | $84 | $132 | – |
| % Margin | 23.8% | 15.2% | 23.9% | – |
| Net Income | $82 | $41 | $76 | – |
| % Margin | 14.4% | 7.5% | 13.7% | – |
| EPS Diluted | 0.36 | 0.18 | 0.33 | – |
| % Growth | 100% | -45.5% | – | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |